Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the major intracellular cation, essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. Dextrose provides caloric supplementation.
Potassium chloride dissociates into potassium ions, which are essential for maintaining cellular membrane potential, nerve impulse transmission, cardiac contractility, and acid-base balance. Replacement of potassium corrects hypokalemia.
Intravenous infusion at a rate not exceeding 10 mEq/h (using 0.11% potassium chloride in 5% dextrose), typically 10-20 mEq over 4-6 hours for mild hypokalemia, with a maximum concentration of 40 mEq/L via peripheral line.
20-40 mEq potassium chloride intravenously per dose, infused at a rate not exceeding 10 mEq/hour (or 20 mEq/hour in critical care settings), repeated as needed based on serum potassium levels. Maximum daily dose typically 200 mEq.
None Documented
None Documented
Potassium has no true elimination half-life as it is homeostatically regulated; the terminal half-life of a potassium load is approximately 8-12 hours in healthy individuals, but this is highly variable and dependent on renal function, aldosterone status, and body stores. In anuric patients, potassium clearance is minimal, and dangerous accumulation can occur within hours.
Potassium chloride does not have a classic elimination half-life as it is an endogenous electrolyte. The terminal half-life of exogenous potassium is approximately 2-3 hours in healthy individuals, reflecting rapid cellular uptake and renal clearance. In renal impairment, half-life is prolonged.
Primarily renal; >90% of potassium is excreted by the kidneys, with approximately 10% lost in feces. In steady state, urinary potassium excretion matches dietary intake (typically 40-120 mEq/day). Dextrose is completely metabolized; unchanged dextrose excretion is negligible (<1% renal) in normoglycemic individuals.
Renal excretion is the primary route; >90% of potassium is excreted by the kidneys, with a small amount lost in feces (via gastrointestinal secretion) and negligible biliary excretion. Renal elimination is regulated by aldosterone and tubular secretion.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement